A patient with DKA is being treated with insulin. What abnormality is likely to develop in this patient?
## Core Concept
The core concept here involves the management of Diabetic Ketoacidosis (DKA) with insulin and the potential complications that can arise from this treatment. DKA is a serious complication of diabetes characterized by hyperglycemia, metabolic acidosis, and increased ketone bodies. Insulin is a cornerstone in the treatment of DKA as it helps to decrease glucose production in the liver, increase glucose uptake by cells, and reduce ketone body formation.
## Why the Correct Answer is Right
The correct answer, , involves the development of hypokalemia. When insulin is administered to a patient with DKA, it drives potassium ions into cells, leading to a decrease in serum potassium levels. This is because insulin promotes the uptake of glucose and potassium into cells by stimulating the Na+/H+ ATPase pump, which leads to an increase in cellular potassium uptake. In the context of DKA, patients often have a total body potassium deficit due to osmotic diuresis caused by hyperglycemia. Therefore, the administration of insulin can lead to a rapid drop in serum potassium levels, potentially causing hypokalemia.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because, although fluid replacement is crucial in the management of DKA, the direct administration of insulin does not primarily cause fluid overload. Fluid overload can occur due to aggressive fluid resuscitation but is not a direct consequence of insulin therapy.
- **Option B:** This option is incorrect because, while metabolic acidosis is a feature of DKA, the administration of insulin actually helps to correct the acidosis by reducing ketone body production. Insulin does not cause acidosis; rather, it is part of the treatment that helps to resolve it.
- **Option C:** This option might seem plausible because hypoglycemia can occur with insulin therapy. However, the question specifically asks about an abnormality likely to develop in the context of DKA treatment with insulin, and while hypoglycemia is a risk, the question seems to point towards an electrolyte imbalance or another complication directly related to insulin administration in DKA.
## Clinical Pearl / High-Yield Fact
A critical clinical pearl in the management of DKA is the importance of monitoring and replenishing potassium levels when administering insulin. The risk of hypokalemia is high, and guidelines often recommend adding potassium to the intravenous fluids (if the patient's potassium level is not significantly elevated) to prevent this complication. This is a high-yield fact because failing to address hypokalemia can lead to serious cardiac arrhythmias and muscle weakness.
## Correct Answer: D. Hypokalemia